Human Subjects Research Protections Outreach Project
人类受试者研究保护外展项目
基本信息
- 批准号:6777806
- 负责人:
- 金额:$ 25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-09-01 至 2007-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The prote(_tion of human research subjects is paramount during the course of human research. With this overall goal in mind, the Human Subjects Research (HSR) Enhancements Program has called upon large academic research centers to share HSR systems improvements with smaller institutions that lack the resources to make such enhancements on their own. Together with the other members of the Dana-Farber/Partner's Cancer Care (DF/PCC), the DFCI has established affiliations with 13 community-based hospitals throughout the New England area. The DFCI now seeks to extend newly developed HSR tools and educational initiatives to its affiliated community-based hospitals through the Network Affiliate Program (NAP). In AIM I, we will provide the NAP hospitals with access to our centralized computer systems to speed the transmission of protocol information and adverse event reports between the DFIPCC and the NAP hospitals. In AIM II, educational workshops, presentations, IRB mentoring and other educational resource materials will be offered to investigators, study team members and IRB administrators/members at each of the NAP hospital. In AIM III, we will provide a traveling Clinical Research Coordinator (CRC), based in the Network Office of the DFCI, who will monitor HSR at each NAP hospital to facilitate the development of up-to-date HSR practices and procedures, the identification of resource needs, and the process of HSR accreditation. In AIM IV, resources developed to educate potential Human Research Subjects about HSR and to inform the public about clinical trials at the more extensive Dana-Farber/Harvard Cancer Center will be extended to these affiliated community-based hospitals. Safety is enhanced when all parties understand
their roles and responsibilities during clinical research, and when tools are available to manage all aspects of such studies. By improving education and information management at our affiliated hospitals, we will enhance the ability of our affiliated institutions to assure the safety of human research subjects cared for at these sites. We expect that this approach will provide a model whereby other Comprehensive Cancer Centers can extend their systems and expertise to smaller affiliated institutions.
在人类研究过程中,保护人类研究对象是至关重要的。考虑到这一总体目标,人类受试者研究(HSR)增强计划呼吁大型学术研究中心与缺乏资源自行进行此类增强的小型机构共享HSR系统改进。与丹娜法伯/合作伙伴的癌症护理(DF/PCC)的其他成员一起,DFCI已与整个新英格兰地区的13家社区医院建立了联系。DFCI现在寻求通过网络附属计划(NAP)将新开发的HSR工具和教育计划扩展到其附属的社区医院。在AIM I中,我们将为NAP医院提供访问我们的中央计算机系统的权限,以加快DFIPCC和NAP医院之间的协议信息和不良事件报告的传输。在AIM II中,将向每个NAP医院的研究者、研究团队成员和IRB管理员/成员提供教育研讨会、演示文稿、IRB指导和其他教育资源材料。在AIM III中,我们将在DFCI的网络办公室提供一名旅行临床研究协调员(CRC),他将在每个NAP医院监测HSR,以促进最新HSR实践和程序的发展,确定资源需求以及HSR认证过程。在AIM IV中,为教育潜在的人类研究受试者了解HSR并向公众宣传更广泛的Dana-Farber/哈佛癌症中心的临床试验而开发的资源将扩展到这些附属社区医院。当所有各方都了解时,安全性得到提高
他们在临床研究中的角色和职责,以及何时可以使用工具来管理此类研究的所有方面。通过改善附属医院的教育和信息管理,我们将提高附属机构的能力,以确保在这些研究中心接受治疗的人类研究受试者的安全。我们希望这种方法将提供一种模式,使其他综合癌症中心可以将其系统和专业知识扩展到较小的附属机构。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
"Entering a Clinical Trial: Is it Right for You?": a randomized study of The Clinical Trials Video and its impact on the informed consent process.
- DOI:10.1002/cncr.26438
- 发表时间:2012-04-01
- 期刊:
- 影响因子:6.2
- 作者:Hoffner B;Bauer-Wu S;Hitchcock-Bryan S;Powell M;Wolanski A;Joffe S
- 通讯作者:Joffe S
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Barrett J. Rollins其他文献
Chemokin mit N-terminalen Deletionsmutationen
趋化因子 N 末端缺失突变
- DOI:
- 发表时间:
1996 - 期刊:
- 影响因子:0
- 作者:
Barrett J. Rollins;Yujun Zhang - 通讯作者:
Yujun Zhang
Chemokines and disease
趋化因子与疾病
- DOI:
10.1038/84209 - 发表时间:
2001-02-01 - 期刊:
- 影响因子:27.600
- 作者:
Craig Gerard;Barrett J. Rollins - 通讯作者:
Barrett J. Rollins
Barrett J. Rollins的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Barrett J. Rollins', 18)}}的其他基金
Fortieth Annual Meeting of the Society for Leukocyte Biology
白细胞生物学学会第四十届年会
- 批准号:
7332762 - 财政年份:2007
- 资助金额:
$ 25万 - 项目类别:
2004 Gordon Research Conference on Chemotactic Cytokines
2004 年戈登趋化细胞因子研究会议
- 批准号:
6807332 - 财政年份:2004
- 资助金额:
$ 25万 - 项目类别:
Molecular Pathobiology of Langerhans Cell Histiocytosis
朗格汉斯细胞组织细胞增多症的分子病理学
- 批准号:
7033933 - 财政年份:2003
- 资助金额:
$ 25万 - 项目类别:
Molecular Pathobiology of Langerhans Cell Histiocytosis
朗格汉斯细胞组织细胞增多症的分子病理学
- 批准号:
6582410 - 财政年份:2003
- 资助金额:
$ 25万 - 项目类别:
Molecular Pathobiology of Langerhans Cell Histiocytosis
朗格汉斯细胞组织细胞增多症的分子病理学
- 批准号:
7209754 - 财政年份:2003
- 资助金额:
$ 25万 - 项目类别:
Molecular Pathobiology of Langerhans Cell Histiocytosis
朗格汉斯细胞组织细胞增多症的分子病理学
- 批准号:
6734733 - 财政年份:2003
- 资助金额:
$ 25万 - 项目类别:
Molecular Pathobiology of Langerhans Cell Histiocytosis
朗格汉斯细胞组织细胞增多症的分子病理学
- 批准号:
6875010 - 财政年份:2003
- 资助金额:
$ 25万 - 项目类别:
Molecular Pathobiology of Langerhans Cell Histiocytosis
朗格汉斯细胞组织细胞增多症的分子病理学
- 批准号:
6471618 - 财政年份:2002
- 资助金额:
$ 25万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 25万 - 项目类别:
Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 25万 - 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 25万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 25万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 25万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 25万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 25万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 25万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 25万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 25万 - 项目类别: